Trials of pharmacological interventions for Tourette Syndrome: A systematic review

Behavioural Neurology

Volumn 26, Issue 4, 2013, Pages 265-273

  Waldon, Karen ^a   Hill, Jonathan ^a   Termine, Cristiano ^b   Balottin, Umberto ^c   Cavanna, Andrea Eugenio ^a,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Drug therapy; movement disorder; pharmacological treatment; randomised controlled trial; tics; Tourette Syndrome

Indexed keywords

ARIPIPRAZOLE; ATOMOXETINE; BACLOFEN; CANNABINOID DERIVATIVE; CLONIDINE; DELTA 9 TETRAHYDROCANET NABINOL; DESIPRAMINE; ETIRACETAM; FLUOXETINE; FLUTAMIDE; GUANFACINE; HALOPERIDOL; MECAMYLAMINE; METOCLOPRAMIDE; NICOTINE; OLANZAPINE; ONDANSETRON; PERGOLIDE; PIMOZIDE; RISPERIDONE; SELEGILINE; SULPIRIDE; TALIPEXOLE; TIAPRIDE; TOPIRAMATE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; APPETITE; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; CLINICAL EFFECTIVENESS; COMORBIDITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EFFECT SIZE; EVIDENCE BASED PRACTICE; FATIGUE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERPROLACTINEMIA; HYPOKINESIA; IRRITABILITY; NAUSEA; NAUSEA AND VOMITING; OPEN STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDATION; SIDE EFFECT; SOCIAL PHOBIA; SOMNOLENCE; SYSTEMATIC REVIEW; TREMOR; UNSPECIFIED SIDE EFFECT; VOMITING; WEIGHT GAIN;

EID: 84874054690     PISSN: 09534180     EISSN: 18758584     Source Type: Journal    
DOI: 10.3233/BEN-2012-120269     Document Type: Article

References (80)

1. World Health Organisation. The International Classification of Diseases, 10th ed., Geneva, 1992.
2. A.E. Cavanna, S. Servo, F.Monaco and M.M. Robertson, The behavioural spectrum of Gilles de la Tourette Syndrome, J Neuropsychiatry Clin Neurosci 21(1) (2009), 13-23.
3. J.F. Leckman, M.T. Hardin,M.A. Riddle, J. Stevenson, S.I. Ort and D.J. Cohen, Clonidine treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry 48(4) (1991), 324-328.
4. J. Jankovic, J. Jimenez-Shahed and L.W. Brown, A randomised, double-blind placebo-controlled study of topiramate in the treatment of Tourette Syndrome, J Neurol Neurosurg Psychiatry 81 (2010), 70-73.
5. M.S. George, M.R. Trimble and M.M.Robertson, Fluvoxamine and Sulpiride in Comorbid Obsessive-Compulsive Disorder and Gilles de la Tourette Syndrome, Hum Psychopharmacol 8(5) (1993), 327-334. (Pubitemid 24038675)
6. B. Kadesjo and C. Gillberg, Tourette's disorder: epidemiology and comorbidity in primary school children, J Am Acad Child Adolesc Psychiatry 39(5) (2000), 548-555. (Pubitemid 30238822)
7. M.M. Robertson, V. Eapen and A.E. Cavanna, The international prevalence, epidemiology, and clinical phenomenology of Tourette Syndrome: a cross-cultural perspective, J Psychosom Res 67(6) (2009), 475-483.
8. M.M. Robertson, Gilles de la Tourette syndrome: the complexities of phenotype and treatment, Br J Hosp Med (Lond) 72(2) (2011), 100-107.
9. C.M. Eddy,H.E.Rickards and A.E. Cavanna, Treatment strategies for tics in Tourette Syndrome, Ther Adv Neurol Disord 4(1) (2011), 25-25.
10. M. Porta, M. Sassi, F. Ali, A.E. Cavanna and D. Servello, Neurosurgical treatment for Gilles de la Tourette syndrome: the Italian perspective, J Psychosom Res 67(6) (2009), 585-590.
11. C. Verdellen, J. van de Griendt, A. Hartmann and T. Murphy, European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions, Eur Child Adolesc Psychiatry 20(4) (2011), 197-207.
12. L.Wu, H. Li and L. Kang, 156 cases of Gilles de la Tourette's syndrome treated by acupunture, J Tradit Chin Med 16(3) (1996), 211-213.
13. M.S. Ross and H. Modolfsky, A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome, Am J Psychiatry 135(5) (1978), 585-587. (Pubitemid 8329032)
14. E. Shapiro, A.K. Shapiro, G. Fulop, M. Hubbard, J.Mandeli, J. Nordlie and R.A. Phillips, Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome, Arch Gen Pychiatry 46(8) (1989), 722-730. (Pubitemid 19198099)
15. L. Scahill, J.F. Leckman, R.T. Schultz, L. Katsovich and B.S. Peterson, A Placebo-controlled trial of risperidone in Tourette Syndrome, Neurology 60(7) (2003), 1130-1135. (Pubitemid 36418773)
16. R. Bruggeman, C. van der Linden, J.K. Buitelar, G.S. Gericke, S.M. Hawkridge and J.A. Temlett, Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study, J Clin Psychiatry 62(1) (2001), 50-56. (Pubitemid 32154319)
17. M. Onofrj, C. Paci, G. D'Andreammatteo and L. Toma, Olanzapine in severe Gilles de la Tourette syndrome: a 52 week double blind crossover study vs. low-dose pimozide, J Neurol 247(6) (2000), 443-446. (Pubitemid 30433558)
18. C.G. Goetz, C.M. Tanner, R.S. Wilson, V.S. Carrol, P.G. Como and K.M. Shannon, Clonidine and Gilles de la Tourette syndrome: double-blind study using objective rating methods, Ann Neurol 21(3) (1987), 307-310. (Pubitemid 17035288)
19. L. Scahill, P.B. Chappell, Y.S. Kim, R.T. Schultz, L. Katsovich, E. Shepherd, A.F.Arnsten, D.J.Cohen and J.F. Leckman, A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder, Am J Psychiatry 158(7) (2001), 1067-1074. (Pubitemid 32623110)
20. Y. Du, H. Li, A. Vance, Y. Zhong, F. Jiao, H.Wang, M.Wang, L. Su, D. Yu, S. Ma and J. Wu, Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders, Aust N Z J Psychiatry 42(9) (2008), 807-813.
21. H.S. Singer, J. Wendlandt, M. Krieger and J. Giulliano, Baclofen Treatment in Tourette syndrome: A double-blind, placebo-controlled, crossover trial, Neurology 56(5) (2001), 599-604. (Pubitemid 32209991)
22. M.M. Robertson and J.S. Stern, Gilles de la Tourette Syndrome: symptomatic treatment based on evidence, Eur Child Adolesc Psychiatry 9(1) (2000), 60-75.
23. C.L.Smith-Hicks, D.D.Bridges, N.P. Paynter andH.S. Singer, A Double Blind Randomized Placebo Control Trial of Levetiracetam in Tourette Syndrome, Mov Disord 22(12) (2007), 1764-1770. (Pubitemid 47597600)
24. D.L.Gilbert, G. Sethuraman, L. Sine, S. Peters and F.R. Sallee, Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial, Neurology 54(6) (2000), 1310-1315. (Pubitemid 30174052)
25. P. Toren, A. Weizman, S. Ratner, D. Cohen and N. Laor, Ondansetron treatment in Tourette's disorder: A 3-week, randomized, double-blind, placebo-controlled study, J Clin Psychiatry 66(4) (2005), 499-503. (Pubitemid 40593579)
26. A.A. Silver, R.D. Shytle, K.H. Sheehan, D.V. Sheehan, A. Ramos and P.R. Sanberg, Multicentre, double-blind, placebocontrolled study ofmecamylaminemonotherapy for Tourette's disorder, J Am Acad Child Adolesc Psychiatry 40(9) (2001), 1103-1110. (Pubitemid 32803824)
27. K.R. Muller-Vahl, U. Schneider, H. Prevedel, K. Theloe, H. Kolbe, T. Daldrup and H.M. Emrich, Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette Syndrome: a 6-week randomized trial, J Clin Psychiatry 64(4) (2003), 459-465. (Pubitemid 36547292)
28. F.R. Sallee, L.Nesbitt, C. Jackson, L. Sine and G. Sethuraman, Relative Efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder, Am J Psychiatry 154(8) (1997), 1057-1062. (Pubitemid 27328819)
29. T. Pringsheim and C. Marras, Pimozide for tics in Tourette's Syndrome, Cochrane Database Syst Rev 15(2) (2009), CD006996.
30. F.R. Sallee, D. Dougherty, G. Sethuraman and N. Vrindavanam, Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's Syndrome, Biol Psychiatry 40(10) (1996), 1044-1050. (Pubitemid 26391682)
31. D.L. Gilbert, J.R. Batterson, G. Sethuraman and F.R. Sallee, Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial, J Am Acad Child Adolesc Psychiatry 43(2) (2004), 206-214.
32. Y. Dion, L. Annable and P. Sandor, G, C. Risperidone in the treatment of Tourette Syndrome: A double-blind, placebocontrolled trial, J Clin Psychopharmacol 22(1) (2002), 31-39. (Pubitemid 34101290)
33. A.O. Alao, K. Malhotra and M.J. Dewan, Comparing the side effect profile of the atypical antipsychotics, West Afr J Med 21(4) (2002), 313-315.
34. National Institute for Health and Clinical Excellence. Clinical guideline CG43 Obesity, 2006.
35. C.M. Eddy, R. Rizzo, M. Gulisano, A. Agodi, M. Barchitta, P. Cali, M.M. Robertson, A.E. Cavanna, Quality of life in young people with Tourette Syndrome: a controlled study, J Neurol 258(2) (2011), 291-301.
36. C.G. Goetz, G.T. Stebbins and J.A. Thelen, Talipexole and adult Gilles de la Tourette's Syndrome: Double-Blind, Placebo-Controlled Clinical Trial, Mov Disord 9(3) (1994), 315-317. (Pubitemid 24150116)
37. D.L. Gilbert, L. Dure, G. Sethuraman, D. Raab, J, L. and F.R. Sallee, Tic reductionwith pergolide in a randomized controlled trial in children, Neurology 60(4) (2003), 606-611. (Pubitemid 36246077)
38. C. Eggers, A. Rothenberger and U. Berghaus, Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride, Eur Arch Psychiatr Neurol Sci 237(4) (1988), 223-229.
39. R. Nicholson, B. Craven-Thuss, J. Smith, B.D.McKinlay, F.X. Castellanos, A randomised, double-blind placebo-controlled trial of Metoclopramide for the treatment of Tourette's disorder, J Am Acad Child Adolesc Psychiatry 44(7) (2005), 640-646. (Pubitemid 40875358)
40. L. Scahill, M.A. Riddle, R.A. King, M.T. Hardin, A. Rasmusson, R.W. Makuch and J.F. Leckman, Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study, J Child Adolesc. Psychopharmacol 7(2) (1997), 75-85. (Pubitemid 27421346)
41. A.J.Allen, R.M.Kurlan, D.L.Gilbert, B.J. Coffey, S.L. Linder, D.W. Lewis, P.K.Winner, D.W. Dunn, L.S. Dure, F.R. Sallee, D.R. Milton, M.L. Mintz, R.K. Ricardi, G. Erenberg, L.L. Layton, P.D. Feldman, D.K. Kelsey and T.J. Spencer, Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders, Neurology 65(12) (2005), 1941-1949. (Pubitemid 43970115)
42. H.S. Singer, J. Brown, S. Quaskey, L.A. Rosenberg, E.D.Mellits and M.B. Denckla, The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind, placebo-controlled study with clonidine and desipramine, Pediatrics 95(1) (1995), 74-81.
43. B.S. Peterson, H. Zhang, G. Anderson and J.F. Leckman, A Double-Blind, Placebo-Controlled, Crossover trial of an antiandrogen in the treatment of Tourette's Syndrome, J Clin Psychopharmacol 18(4) (1998), 324-331. (Pubitemid 28353876)
44. B.S. Peterson, J.F. Leckman, L. Scahill and F.Naftolin, Steroid hormones and Tourette's syndrome: Early experience with antiandrogen therapy, J Clin Psychopharmacol 14(2) (1994), 131-135. (Pubitemid 24120712)
45. J.T. Walkup, L.A. Rosenberg, J. Brown and H.S. Singer, The validity of instruments measuring tic severity in Tourette's syndrome, J Am Acad Child Adolesc Psychiatry 31(3) (1992), 472-477.
46. A.A. Silver, R.D. Shytle, M.K. Philipp, B.J. Wilkinson, B. McConville and P.R. Sanberg, Transdermal Nicotine and Haloperidol in Tourette's Disorder: A double-blind placebocontrolled study, J Clin Psychiatry 62(9) (2001), 707-714. (Pubitemid 32994934)
47. E.F. Hedderick, C.M. Morris and H.S. Singer, Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome, Pediatr Neurol 40(6) (2009), 420-425.
48. A. Feigin, R. Kurlan, M.P. McDermott, J. Beach, T. Dimitsopulos, C.A. Brower, L. Chapieski, K. Trinidad, P. Como and J. Jankovic, A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder, Neurology 46(4) (1996), 965-968. (Pubitemid 26134635)
49. A. Braun, M.M. Mouradian, E. Mohr, G. Fabbrini and T.N. Chase, Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders, J Neurol Neurosurg Psychiatry 52(5) (1989), 631-635. (Pubitemid 19151722)
50. A.K. Shapiro and E. Shapiro, Controlled study of pimozide vs placebo in Tourette's syndrome, J Am Acad Child Psychiatry 23(2) (1984), 161-173. (Pubitemid 14066109)
51. M. Gulisano, P.V. Cali, A.E. Cavanna, C. Eddy, H. Rickards and R. Rizzo, Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome, Neurol Sci 32(6) (2011), 1213-1217.
52. B. Kim, C. Lee, J. Hwang, M. Shin and S. Cho, Effectiveness and safety of risperidone for children and adolescents with chronic tic or Tourette disorders in Korea, J Child Adolesc Psychopharmacol 15(2) (2005), 318-324. (Pubitemid 40734111)
53. G.R. Gaffney, P.J. Perry, B.C. Lund, K.A. Bever-Stille, S. Arndt and S. Kuperman, Risperidone verus clonidine in the treatment of children and adolescents with Tourette's syndrome, J Am Acad Child Adolesc Psychiatry 41(3) (2002), 330-336. (Pubitemid 38338155)
54. I. Drtilkova, B. Balastikova and H. Lemanova, Tiapride, clonazepam and clonidine in children with tic and comorbid hyperkinetics disorder: Clinical EEG study, Ceska Slov Psychiatr 93(3) (1997), 54-78. (Pubitemid 28117211)
55. I. Drtilkova, B. Balastikova, H. Lemanova and J. Zak, Clonazepam, clonidine and tiapride in children with tic disorder, Homeost Health Dis 37(5) (1996), 216. (Pubitemid 127528628)
56. F.J. Jimenez-Jimenez and P.J. Garcia-Ruiz, Pharmacological Options for the treatment of Tourette's disorder, Drugs 61(15) (2001), 2207-2220. (Pubitemid 34074802)
57. M.M. Robertson, V. Schnieden and A.J. Lees, Management of Gilles de la Tourette syndrome using Sulpiride, Clin Neuropharmacol 13(3) (1990), 229-235. (Pubitemid 20181214)
58. C. Ho, H. Chen, N. Chiu, E. Shen and H. Lue, Short-term treatment of children and adolescents with Tourette syndrome or chronic tic disorder, J Formos Med Assoc 108(10) (2009), 788-793.
59. V. Eapen, C.L. Katona, T.R. Barnes and M.M. Robertson, Sulpiride-induced tardive dyskinesia in a person with Gilles de la Tourette syndrome, J. Psychopharmacol 7(3) (1993), 290-292. (Pubitemid 23271049)
60. A.E. Cavanna, C. Selvini, C. Termine, C. Luoni, C.M. Eddy and H. Rickards, Tolerability profile of aripiprazole in patients with Tourette's syndrome, J Psychopharmacol 2011, Epub ahead of print.
61. K. Lewis, L. Rappa, D.A. Sherwood-Jachimowicz and M. Larosse-Pierre, Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report, J Pharm Pract 23(3) (2010), 239-244.
62. J.F. Leckman, J. Detlor, D.F. Harcherik, S. Ort, B.A. Shaywitz and D.J. Cohen, Short-and long-term treatment of Tourette's syndrome with clonidine: a clinical perspective, Neurology 35(3) (1985), 343-351. (Pubitemid 15100674)
63. S. Kuo, J. Topiramate in treatment of Tourette syndrome, Clin Neuropharmacol 33(1) (2010), 32-34.
64. T.Y. Nelson, M.T. Bost and P.S. Lesser, Topiramate in children and adolescents with Tourette syndrome: A case series, Journal of Pediatric Neurology 5(1) (2007), 1304-2580.
65. F.S. Abuzzhahab and L. Victoria, Control of Tourette's syndrome with topiramate, Am J Psychiatry 158(6) (2001), 968.
66. Y. Awaad, A.M. Michon, S. Minarik and T. Rizk, Levetiracetam in Tourette syndrome: A randomized double blind, placebo controlled study, Pediatr Neurol 7(3) (2009), 257-263.
67. Y. Awaad, A.M. Michon and S. Minarik, Long-term use of levetiracetam to treat tics in children and adolescents with Tourette syndrome, Pediatr Neurol 5(3) (2007), 209-214. (Pubitemid 47202400)
68. Y. Awaad, A.M. Michon and S. Minarik, Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome, Mov Disord 20(6) (2005), 714-718. (Pubitemid 41056938)
69. A. Fernandez-Jaen, D.M. Fernandez-Mayoralas, N. Munoz-Jareno and B. Calleja-Perez, An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome, Eur J Paediatr Neurol 13(6) (2009), 541-545.
70. A.E. Cavanna, A. Schrag, D. Morley, M. Orth, M.M. Robertson, E. Joyce, H.D. Critchley and C. Selai, The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL): development and validation. Neurology 71(18) (2008), 1410-1416.
71. T. Pringsheim and T. Steeves, Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders, Cochrane Database of Systematic Reviews, 2011, No. 4, CD007990.
72. P.R. Sanberg, R.D. Shytle and A.A. Silver, Treatment of Tourette's syndrome with mecamylamine in Tourette's syndrome: a two-year retrospective case study, Lancet 352(9129) (1998), 705-706.
73. Y. Awaad, Tics in Tourette syndrome: New treatment options, J Child Neurol 14(5) (1999), 316-319. (Pubitemid 29239188)
74. Y.Worbe, S. Palminteri, A.Hartmann,M.Vidailhet, S. Lehericy and M. Pessiglione, Reinforcement learning and gilles de la tourette syndrome: dissociation of clinical phenotypes and pharmacological treatments, Arch Gen Psychiatry 68(12) (2011), 1257-1266.
75. P.R. Sanberg, A.A. Silver, R.D. Shytle, M.K. Philipp, D.W. Cahill, H.M. Fogelson and B.J. McConville, Nicotine for the treatment of Tourette's syndrome, Pharmacol Ther 74(1) (1997), 21-25. (Pubitemid 27337351)
76. J.F. Lipinski, F.R. Sallee, C. Jackson and G. Sethuraman, Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide, Mov Disord 12(3) (1997), 402-407. (Pubitemid 27216140)
77. B.J. McConville, P.R. Sanberg, M.H. Fogelson and J. King, The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder, Biol Psychiatry 31(8) (1992), 832-840.
78. K.R. Muller-Vahl, The treatment of Tourette's syndrome: current opinions, Expert Opin Pharmacother 3(7) (2002), 899-914. (Pubitemid 34752508)
79. A.A. Silver, R.D. Shytle and P.R. Sanberg, Mecamylamine in Tourette's syndrome: a two-year retrospective case study, J Child Adolesc Psychopharmacol 10(2) (2000), 59-68. (Pubitemid 30490913)
80. P. Toren, N. Laor, D.J. Cohen, L. Wolmer and A. Weizman, Ondansetron treatment in patients with Tourette's syndrome, Int Clin Psychopharmacol 14(6) (1999), 373-376. (Pubitemid 29531387)